Adenomatous Polyposis Coli (APC) regulates multiple signaling pathways by enhancing glycogen synthase kinase-3 (GSK-3) activity

Journal of Biological Chemistry

Volumn 287, Issue 6, 2012, Pages 3823-3832

  Valvezan, Alexander J ^a   Zhang, Fang ^a   Diehl, J Alan ^a   Klein, Peter S ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOMATOUS POLYPOSIS COLI; CELLULAR PROCESS; GLYCOGEN SYNTHASE; GLYCOGEN SYNTHASE KINASE-3; SIGNALING PATHWAYS; WNT SIGNALING;

ANTIBIOTICS; CHEMICAL ACTIVATION; DISSOCIATION; ENZYME INHIBITION; PHOSPHORYLATION; STABILIZATION;

SIGNALING;

APC PROTEIN; AXIN; BETA CATENIN; CASEIN KINASE IALPHA; GLYCOGEN SYNTHASE KINASE 3; MAMMALIAN TARGET OF RAPAMYCIN; PROTEIN KINASE B; SMALL INTERFERING RNA; TAU PROTEIN; WNT PROTEIN; WNT3A PROTEIN;

AMINO TERMINAL SEQUENCE; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; ENZYME REGULATION; ENZYME SUBSTRATE; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; REPORTER GENE; SIGNAL TRANSDUCTION;

ADENOMATOUS POLYPOSIS COLI PROTEIN; AXIN PROTEIN; BETA CATENIN; GLYCOGEN SYNTHASE KINASE 3; HEK293 CELLS; HUMANS; LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN-6; TOR SERINE-THREONINE KINASES; WNT PROTEINS; WNT SIGNALING PATHWAY;

EID: 84863012691     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M111.323337     Document Type: Article

References (66)

1. Kockeritz, L., Doble, B., Patel, S., and Woodgett, J. R. (2006) Glycogen synthase kinase-3 - an overview of an over-achieving protein kinase. Current Drug Targets 7, 1377-1388 (Pubitemid 44718298)
2. Inoki, K., Ouyang, H., Zhu, T., Lindvall, C., Wang, Y., Zhang, X., Yang, Q., Bennett, C., Harada, Y., Stankunas, K., Wang, C. Y., He, X., MacDougald, O. A., You, M., Williams, B. O., and Guan, K. L. (2006) TSC2 integrates Wnt and energy signals via a coordinated phosphorylation by AMPK and GSK3 to regulate cell growth. Cell 126, 955-968 (Pubitemid 44310775)
3. Wang, Q., Zhou, Y., Wang, X., and Evers, B. M. (2006) Glycogen synthase kinase-3 is a negative regulator of extracellular signal-regulated kinase. Oncogene 25, 43-50 (Pubitemid 43050002)
4. Fuentealba, L. C., Eivers, E., Ikeda, A., Hurtado, C., Kuroda, H., Pera, E. M., and De Robertis, E. M. (2007) Integrating patterning signals: Wnt/GSK3 regulates the duration of the BMP/Smad1 signal. Cell 131, 980-993 (Pubitemid 350138081)
5. Fukuda, T., Kokabu, S., Ohte, S., Sasanuma, H., Kanomata, K., Yoneyama, K., Kato, H., Akita, M., Oda, H., and Katagiri, T. (2010) Canonical Wnts and BMPs cooperatively induce osteoblastic differentiation through a GSK3β-dependent and β-catenin-independent mechanism. Differentiation 80, 46-52
6. Jope, R. S., and Roh, M. S. (2006) Glycogen synthase kinase-3 (GSK3) in psychiatric diseases and therapeutic interventions. Curr. Drug Targets 7, 1421-1434 (Pubitemid 44718302)
7. Hernández, F., de Barreda, E. G., Fuster-Matanzo, A., Goñi-Oliver, P., Lucas, J. J., and Avila, J. (2009) The role of GSK3 in Alzheimer disease. Brain Research Bulletin 80, 248-250
8. Luo, J. (2009) Glycogen synthase kinase 3β (GSK3β) in tumorigenesis and cancer chemotherapy. Cancer Letters 273, 194-200
9. Cross, D. A., Alessi, D. R., Cohen, P., Andjelkovich, M., and Hemmings, B. A. (1995) Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378, 785-789 (Pubitemid 26004411)
10. McManus, E. J., Sakamoto, K., Armit, L. J., Ronaldson, L., Shpiro, N., Marquez, R., and Alessi, D. R. (2005) Role that phosphorylation of GSK3 plays in insulin and Wnt signaling defined by knockin analysis. EMBO J. 24, 1571-1583 (Pubitemid 40646447)
11. Dajani, R., Fraser, E., Roe, S. M., Young, N., Good, V., Dale, T. C., and Pearl, L. H. (2001) Crystal structure of glycogen synthase kinase 3β: structural basis for phosphate-primed substrate specificity and autoinhibition. Cell 105, 721-732 (Pubitemid 32635102)
12. Ding, V. W., Chen, R. H., and McCormick, F. (2000) Differential regulation of glycogen synthase kinase 3β by insulin and Wnt signaling. J. Biol. Chem. 275, 32475-32481
13. Cook, D., Fry, M. J., Hughes, K., Sumathipala, R., Woodgett, J. R., and Dale, T. C. (1996) Wingless inactivates glycogen synthase kinase-3 via an intracellular signaling pathway which involves a protein kinase C. EMBO J. 15, 4526-4536 (Pubitemid 26294571)
14. MacDonald, B. T., Tamai, K., and He, X. (2009) Wnt/β-catenin signaling: components, mechanisms, and diseases. Dev. Cell 17, 9-26
15. Clevers, H. (2006) Wnt/β-catenin signaling in development and disease. Cell 127, 469-480
16. Salahshor, S., and Woodgett, J. (2005) The links between axin and carcinogenesis. J. Clin. Pathol. 58, 225-236 (Pubitemid 40380314)
17. Paul, S., and Dey, A. (2008) Wnt signaling and cancer development: therapeutic implication. Neoplasma 55, 165-176
18. Peterson-Nedry, W., Erdeniz, N., Kremer, S., Yu, J., Baig-Lewis, S., and Wehrli, M. (2008) Unexpectedly robust assembly of the Axin destruction complex regulates Wnt/Wg signaling in Drosophila as revealed by analysis in vivo. Dev. Biol. 320, 226-241
19. Tolwinski, N. S., Wehrli, M., Rives, A., Erdeniz, N., DiNardo, S., and Wieschaus, E. (2003) Wg/Wnt signal can be transmitted through arrow/LRP5,6 and Axin independently of Zw3/Gsk3β activity. Dev. Cell 4, 407-418 (Pubitemid 36342365)
20. Lee, E., Salic, A., Kruger, R., Heinrich, R., and Kirschner, M. (2003) The roles of APC and Axin derived from experimental and theoretical analysis of the Wnt pathway. PLoS Biol. 1, 116-132
21. Taelman, V. F., Dobrowolski, R., Plouhinec, J. L., Fuentealba, L. C., Vorwald, P. P., Gumper, I., Sabatini, D. D., and De Robertis, E. M. (2010) Wnt signaling requires sequestration of glycogen synthase kinase 3 inside multivesicular endosomes. Cell 143, 1136-1148
22. Wu, G., Huang, H., Garcia Abreu, J., and He, X. (2009) Inhibition of GSK3 phosphorylation of β-catenin via phosphorylated PPPSPXS motifs of Wnt coreceptor LRP6. PLoS ONE 4, e4926
23. Cselenyi, C. S., Jernigan, K. K., Tahinci, E., Thorne, C. A., Lee, L. A., and Lee, E. (2008) LRP6 transduces a canonical Wnt signal independently of Axin degradation by inhibiting GSK3's phosphorylation of β-catenin. Proc. Natl. Acad. Sci. U.S.A. 105, 8032-8037 (Pubitemid 351904702)
24. Piao, S., Lee, S. H., Kim, H., Yum, S., Stamos, J. L., Xu, Y., Lee, S. J., Lee, J., Oh, S., Han, J. K., Park, B. J., Weis, W. I., and Ha, N. C. (2008) Direct inhibition of GSK3β by the phosphorylated cytoplasmic domain of LRP6 in Wnt/β-catenin signaling. PLoS ONE 3, e4046
25. Yang, J., Zhang, W., Evans, P. M., Chen, X., He, X., and Liu, C. (2006) Adenomatous polyposis coli (APC) differentially regulates β-catenin phosphorylation and ubiquitination in colon cancer cells. J. Biol. Chem. 281, 17751-17757 (Pubitemid 44035574)
26. Su, Y., Fu, C., Ishikawa, S., Stella, A., Kojima, M., Shitoh, K., Schreiber, E. M., Day, B. W., and Liu, B. (2008) APC is essential for targeting phosphorylated β-catenin to the SCFβ-TrCP ubiquitin ligase. Mol. Cell 32, 652-661
27. Hinoi, T., Yamamoto, H., Kishida, M., Takada, S., Kishida, S., and Kikuchi, A. (2000) Complex formation of adenomatous polyposis coli gene product and axin facilitates glycogen synthase kinase-3β-dependent phosphorylation of β-catenin and down-regulates β-catenin. J. Biol. Chem. 275, 34399-34406
28. Behrens, J., Jerchow, B. A., Würtele, M., Grimm, J., Asbrand, C., Wirtz, R., Kühl, M., Wedlich, D., and Birchmeier, W. (1998) Functional interaction of an axin homolog, conductin, with β-catenin, APC, and GSK3β. Science 280, 596-599
29. Munemitsu, S., Albert, I., Souza, B., Rubinfeld, B., and Polakis, P. (1995) Regulation of intracellular β-catenin levels by the adenomatous polyposis coli (APC) tumor-suppressor protein. Proc. Natl. Acad. Sci. U.S.A. 92, 3046-3050
30. Kawahara, K., Morishita, T., Nakamura, T., Hamada, F., Toyoshima, K., and Akiyama, T. (2000) Down-regulation of β-catenin by the colorectal tumor suppressor APC requires association with Axin and β-catenin. J. Biol. Chem. 275, 8369-8374 (Pubitemid 30180178)
31. von Kries, J. P., Winbeck, G., Asbrand, C., Schwarz-Romond, T., Sochnikova, N., Dell'Oro, A., Behrens, J., and Birchmeier, W. (2000) Hot spots in β-catenin for interactions with LEF-1, conductin and APC. Nat. Struct. Biol. 7, 800-807
32. Hanson, C. A., and Miller, J. R. (2005) Non-traditional roles for the Adenomatous Polyposis Coli (APC) tumor suppressor protein. Gene 361, 1-12 (Pubitemid 41506930)
33. Forde, J. E., and Dale, T. C. (2007) Glycogen synthase kinase 3: a key regulator of cellular fate. Cell. Mol. Life Sci. 64, 1930-1944 (Pubitemid 47094432)
34. Caldwell, C. M., and Kaplan, K. B. (2009) The role of APC in mitosis and in chromosome instability. Adv. Exp. Med. Biol. 656, 51-64
35. Wakefield, J. G., Stephens, D. J., and Tavare, J. M. (2003) A role for glycogen synthase kinase-3 in mitotic spindle dynamics and chromosome alignment. J. Cell Science 116, 637-646 (Pubitemid 36231302)
36. Phiel, C. J., Zhang, F., Huang, E. Y., Guenther, M. G., Lazar, M. A., and Klein, P. S. (2001) Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen. J. Biol. Chem. 276, 36734-36741
37. Tamai, K., Zeng, X., Liu, C., Zhang, X., Harada, Y., Chang, Z., and He, X. (2004) A mechanism for Wnt coreceptor activation. Molecular Cell 13, 149-156 (Pubitemid 38117123)
38. Hedgepeth, C. M., Deardorff, M. A., Rankin, K., and Klein, P. S. (1999) Regulation of glycogen synthase kinase 3β and downstream Wnt signaling by axin. Mol. Cell. Biol. 19, 7147-7157 (Pubitemid 29441895)
39. Smith, K. J., Levy, D. B., Maupin, P., Pollard, T. D., Vogelstein, B., and Kinzler, K. W. (1994) Wild-type but not mutant APC associates with the microtubule cytoskeleton. Cancer Res. 54, 3672-3675 (Pubitemid 24241176)
40. Xu, L., Corcoran, R. B., Welsh, J. W., Pennica, D., and Levine, A. J. (2000) WISP-1 is a Wnt-1- and β-catenin-responsive oncogene. Genes Dev. 14, 585-595
41. Guo, X., Ramirez, A., Waddell, D. S., Li, Z., Liu, X., and Wang, X. F. (2008) Axin and GSK3- control Smad3 protein stability and modulate TGF signaling. Genes Dev. 22, 106-120
42. Schneikert, J., and Behrens, J. (2006) Truncated APC is required for cell proliferation and DNA replication. Int. J. Cancer 119, 74-79
43. Kofron, M., Klein, P., Zhang, F., Houston, D. W., Schaible, K., Wylie, C., and Heasman, J. (2001) The role of maternal axin in patterning the Xenopus embryo. Dev. Biol. 237, 183-201 (Pubitemid 32844314)
44. Greenberg, S. G., Davies, P., Schein, J. D., and Binder, L. I. (1992) Hydrofluoric acid-treated tau PHF proteins display the same biochemical properties as normal tau. J. Biol. Chem. 267, 564-569
45. Klein, P. S., and Melton, D. A. (1996)Amolecular mechanism for the effect of lithium on development. Proc. Natl. Acad. Sci. U.S.A. 93, 8455-8459 (Pubitemid 26269579)
46. Alessi, D. R., Andjelkovic, M., Caudwell, B., Cron, P., Morrice, N., Cohen, P., and Hemmings, B. A. (1996) Mechanism of activation of protein kinase B by insulin and IGF-1. EMBO J. 15, 6541-6551 (Pubitemid 26413787)
47. Huang, J., Zhang, Y., Bersenev, A., O'Brien, W. T., Tong, W., Emerson, S. G., and Klein, P. S. (2009) Pivotal role for glycogen synthase kinase-3 in hematopoietic stem cell homeostasis in mice. J. Clin. Invest. 119, 3519-3529
48. Kishida, S., Yamamoto, H., Ikeda, S., Kishida, M., Sakamoto, I., Koyama, S., and Kikuchi, A. (1998) Axin, a negative regulator of the wnt signaling pathway, directly interacts with adenomatous polyposis coli and regulates the stabilization of β-catenin. J. Biol. Chem. 273, 10823-10826 (Pubitemid 28204914)
49. Liu, C., Li, Y., Semenov, M., Han, C., Baeg, G. H., Tan, Y., Zhang, Z., Lin, X., and He, X. (2002) Control of β-catenin phosphorylation/degradation by a dual-kinase mechanism. Cell 108, 837-847 (Pubitemid 34327534)
50. Morin, P. J. (1999) β-Catenin signaling and cancer. Bioessays 21, 1021-1030
51. Zeng, X., Tamai, K., Doble, B., Li, S., Huang, H., Habas, R., Okamura, H., Woodgett, J., and He, X. (2005) A dual-kinase mechanism for Wnt co-receptor phosphorylation and activation. Nature 438, 873-877 (Pubitemid 41753071)
52. Mao, J., Wang, J., Liu, B., Pan, W., Farr, G. H., 3rd, Flynn, C., Yuan, H., Takada, S., Kimelman, D., Li, L., and Wu, D. (2001) Low-density lipoprotein receptor-related protein-5 binds to Axin and regulates the canonical Wnt signaling pathway. Mol. Cell 7, 801-809 (Pubitemid 32436440)
53. Zoncu, R., Efeyan, A., and Sabatini, D. M. (2011) mTOR: from growth signal integration to cancer, diabetes and ageing. Nat. Rev. Mol. Cell Biol. 12, 21-35
54. Koehl, G. E., Spitzner, M., Ousingsawat, J., Schreiber, R., Geissler, E. K., and Kunzelmann, K. (2010) Rapamycin inhibits oncogenic intestinal ion channels and neoplasia in APC(Min/+) mice. Oncogene 29, 1553-1560
55. Fujishita, T., Aoki, K., Lane, H. A., Aoki, M., and Taketo, M. M. (2008) Inhibition of the mTORC1 pathway suppresses intestinal polyp formation and reduces mortality in ApcDelta716 mice. Proc. Natl. Acad. Sci. U.S.A. 105, 13544-13549
56. Ahmad, I., Morton, J. P., Singh, L. B., Radulescu, S. M., Ridgway, R. A., Patel, S., Woodgett, J., Winton, D. J., Taketo, M. M., Wu, X. R., Leung, H. Y., and Sansom, O. J. (2011) β-Catenin activation synergizes with PTEN loss to cause bladder cancer formation. Oncogene 30, 178-189
57. Yamazaki, H., and Yanagawa, S. (2003) Axin and the Axin/Arrow-binding protein DCAP mediate glucose-glycogen metabolism. Biochem. Biophys. Res. Commun. 304, 229-235 (Pubitemid 36444559)
58. Park, K. S., Jeon, S. H., Kim, S. E., Bahk, Y. Y., Holmen, S. L., Williams, B. O., Chung, K. C., Surh, Y. J., and Choi, K. Y. (2006) APC inhibits ERK pathway activation and cellular proliferation induced by RAS. J. Cell Science 119, 819-827
59. Miclea, R. L., van der Horst, G., Robanus-Maandag, E. C., Löwik, C. W., Oostdijk, W., Wit, J. M., and Karperien, M. (2011) Apc bridges Wnt/β-catenin and BMP signaling during osteoblast differentiation of KS483 cells. Exp. Cell Res. 317, 1411-1421
60. Chen, H. J., Lin, C. M., Lin, C. S., Perez-Olle, R., Leung, C. L., and Liem, R. K. (2006) The role of microtubule actin cross-linking factor 1 (MACF1) in the Wnt signaling pathway. Genes Dev. 20, 1933-1945 (Pubitemid 44079330)
61. Wang, Y., Azuma, Y., Moore, D., Osheroff, N., and Neufeld, K. L. (2008) Interaction between tumor suppressor adenomatous polyposis coli and topoisomerase IIα: implication for the G2/M transition. Mol. Biol. Cell 19, 4076-4085
62. Brady, M. J., and Saltiel, A. R. (2001) The role of protein phosphatase-1 in insulin action. Rec. Progr. Horm. Res. 56, 157-173
63. Dotti, C. G., Sullivan, C. A., and Banker, G. A. (1988) The establishment of polarity by hippocampal neurons in culture. J. Neurosci. 8, 1454-1468
64. Jiang, H., Guo, W., Liang, X., and Rao, Y. (2005) Both the establishment and the maintenance of neuronal polarity require active mechanisms: critical roles of GSK-3β and its upstream regulators. Cell 120, 123-135 (Pubitemid 40094608)
65. Gärtner, A., Huang, X., and Hall, A. (2006) Neuronal polarity is regulated by glycogen synthase kinase-3 (GSK-3β) independently of Akt/PKB serine phosphorylation. J. Cell Sci. 119, 3927-3934 (Pubitemid 44650866)
66. Shi, S. H., Cheng, T., Jan, L. Y., and Jan, Y. N. (2004) APC and GSK-3β are involved in mPar3 targeting to the nascent axon and establishment of neuronal polarity. Curr. Biol. 14, 2025-2032 (Pubitemid 39547957)